| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0087 | 1 |